Cytek Biosciences, Inc. (CTKB): R&D Expense
$36.47M
Year ended 2025-12-31
$37.26M
Trailing 12 months to 2026-06-30
+1.5%
3-year compound annual growth
+21.6%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $36.47M | -7.4% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $39.40M | -10.8% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $44.15M | +26.7% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $34.86M | +42.6% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $24.44M | +78.5% | 2024-03-13, From 2021-01-01 |
| 2020-12-31 | $13.69M | n/a | 2023-03-01, From 2020-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | $36.47M | -7.4% |
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | $97.31M | -27.9% |
| Quanterix Corp (QTRX) | 2025-12-31 | $35.92M | +15.6% |
| Harvard Bioscience Inc (HBIO) | 2025-12-31 | $8.82M | -15.2% |
| 10x Genomics, Inc. (TXG) | 2025-12-31 | $238.63M | -9.8% |
| 908 Devices Inc. (MASS) | 2025-12-31 | $15.57M | +3.9% |
| Rapid Micro Biosystems, Inc. (RPID) | 2025-12-31 | $13.60M | -6.8% |
| EyePoint, Inc. (EYPT) | 2025-12-31 | $221.04M | +66.3% |
| Bionano Genomics, Inc. (BNGO) | 2025-12-31 | $11.37M | -54.1% |
Compare CTKB, PACB, QTRX, HBIO side by side · Screen every company in Laboratory Analytical Instruments ↗